| http://www.w3.org/ns/prov#value | - In one embodiment, the complexing agents are peptides or other small molecules designed to selectively bind to prions. Preferably, the peptides or small molecules are designed to preferentially bind to PrP.sup.Sc. By "preferentially bind" is
|
